The Pharmacy Hub
- License footprint
- 1 states: FL
“Prescription products are dispensed by independent licensed pharmacies, including our partner pharmacy The Pharmacy Hub (15600 NW 15th Ave, Suite C, Miami, FL 33169; (888) 958-1382; [website])”
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: knowing which pharmacy fills the vial: it names The Pharmacy Hub
The Edit scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $259 a month; its compounded tirzepatide, at $349, is 30% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $259/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Every treatment page carries its price in the open, and beginning requires no card on file. Austin is home to The Edit Health LLC, a management services organization under Texas law, selling GHK-Cu, glutathione, sermorelin and NAD+ protocols beside compounded tirzepatide and semaglutide for weight loss. An independent practice affiliated with it, Arora Health & Aesthetics, does the prescribing; a named partner in Miami, The Pharmacy Hub, does the dispensing. Spanish and English both run on the site.
Yes. The Edit is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
The Edit has no coupon code to enter. New patients are currently quoted $200 for the first month, then $259 a month, and the discount applies on its own. Coupon sites advertising a "The Edit promo code" are not a source we can vouch for.
See how The Edit compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Editorial score · methodology
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something The Edit has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
$349/month is 30% above the $269 median for compounded tirzepatide across the sellers we compare.
Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
A price is shown before the questionnaire starts.
It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Serves all 50 states.
The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
Taken from the terms The Edit publishes. Terms change, so check the current policy before you subscribe.
The Edit lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
The Edit sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Prices re-verified
"$200 first month, then $259 / month". Prepay tiers are billed once upfront: 3 months $575 ($192/mo), 6 months $1,065 ($178/mo).
"$300 first month, then $349 / month". Prepay tiers are billed once upfront: 3 months $855 ($285/mo), 6 months $1,575 ($263/mo).
Check the price yourself before you pay
Every figure here comes from The Edit's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
The Edit names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
“Prescription products are dispensed by independent licensed pharmacies, including our partner pharmacy The Pharmacy Hub (15600 NW 15th Ave, Suite C, Miami, FL 33169; (888) 958-1382; [website])”
The figure The Edit leads with is $200, and it is a first-month rate. From month two the price is $259/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.
For compounded tirzepatide, the median across the sellers we compare is $269/month, so The Edit's $349 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much. Before you pay, compare The Edit's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.
The Edit prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
The Edit tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to The Edit. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against The Edit. How we weigh oversight, disclosure and price is set out in our scoring methodology.
The Edit also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
The Edit is a cheap way to start and an ordinary way to continue. Use the $200 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $259/month before you let it renew twice.
The Bottom Line
The Edit scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $259 a month; its compounded tirzepatide, at $349, is 30% above the $269 median among the sellers we compare.
Starting at $259 a month. Check today's price, then start the intake.
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
If none of these fits, our guide to alternatives to The Edit sets more sellers in the same category beside The Edit on price, states and what the price includes.
Every seller that ships to your state, side by side: Massachusetts, Mississippi, Missouri, Nebraska, New Mexico, North Dakota, South Carolina, Wyoming and every other state.
The words sellers use, defined. Tap any term.
Cited across this The Edit review: primary regulatory filings, and peer-reviewed studies.
Plans start at $200 a month. Whether you qualify is a clinician's decision, made after your intake.